多参数MRI联合病理生物标志物列线图预测乳腺癌HIF-1α表达
回顾性纳入146例乳腺癌患者,按7:3分为训练集103例与验证集43例,评估临床病理、常规MRI、IVIM-DWI及DCE-MRI对HIF-1α表达的预测价值。联合模型(ALN_metastasis+TIC type+D+Kep)在训练集中AUC为0.958,显著优于各单独模型(均P<0.001)。研究提示该列线图可无创预测HIF-1α表达,辅助乳腺癌个体化治疗。
要点
- 联合模型(ALN_metastasis+TIC type+D+Kep)训练集AUC达0.958,显著优于单独模型。
- HIF-1α高表达组腋窝淋巴结转移比例更高、组织学分级更高、边缘不清、TIC-III型更多。
- 高表达组D值更低,Ktrans和Kep值更高,提示弥散受限与灌注增高。
核心结论
- 联合病理与多模态MRI参数的列线图可较准确无创预测乳腺癌HIF-1α表达,AUC为0.958(训练集)。
- 联合模型预测效能显著优于病理模型、常规MRI模型、IVIM-DWI模型及DCE-MRI模型(均P<0.001)。
研究设计与样本
- 回顾性研究,纳入2019至2023年146例接受术前多参数MRI及手术的乳腺癌患者。
- 按7:3随机分为训练集103例与验证集43例,采用多因素logistic回归与ROC分析构建列线图。
关键影像表现/征象
- HIF-1α高表达组较低表达组边缘不清比例更高,时间-信号强度曲线TIC-III型比例更高。
- 高表达组IVIM-DWI参数D值显著低于低表达组(P<0.05)。
- 高表达组DCE-MRI参数Ktrans和Kep值显著高于低表达组(P<0.05)。
诊断标准与关键数值
- 训练集中病理模型AUC为0.765,常规MRI模型AUC为0.732,IVIM-DWI模型AUC为0.771,DCE-MRI模型AUC为0.804。
- 联合模型(ALN_metastasis+TIC type+D+Kep)在训练集中AUC为0.958。
- 联合模型与常规MRI模型比较Z=4.890(P<0.001),与病理模型比较Z=4.429(P<0.001)。
- 联合模型与IVIM模型比较Z=3.724(P<0.001),与DCE-MRI模型比较Z=3.691(P<0.001)。
- HIF-1α高表达组腋窝淋巴结转移比例与组织学分级均显著高于低表达组(P<0.05)。
临床应用与阅片要点
- 报告乳腺多参数MRI时,边缘不清、TIC-III型、D值减低及Ktrans、Kep增高提示HIF-1α高表达可能。
- 联合腋窝淋巴结转移状态与上述MRI征象构建列线图,可用于术前无创评估肿瘤缺氧状态。
局限性
- 回顾性单中心研究设计,样本量为146例,可能存在选择偏倚,需前瞻性多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to assess the predictive value of clinicopathological characteristics, conventional magnetic resonance imaging (MRI), intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI), and dynamic contrast-enhanced MRI (DCE-MRI) parameters for hypoxia-inducible factor-1α (HIF-1α) expression in breast cancer.
MATERIALS AND METHODS: We retrospectively enrolled 146 breast cancer patients receiving preoperative multiparametric MRI and surgery from 2019 to 2023, who were randomly assigned into training (n = 103) and validation (n = 43) cohorts at 7:3 ratio. Multivariate logistic regression and receiver operating characteristic (ROC) curve analyses were conducted, and a nomogram was constructed based on independent predictive factors.
RESULTS: The high-expression group had a higher proportion of axillary lymph node metastasis (ALN_metastasis), advanced histological grades, unclear margin, time intensity curve (TIC)-III type, lower D values, and higher Ktrans and Kep values compared with the low-expression group (P < 0.05). The area under the curves(AUCs) for the pathological, conventional MRI, IVIM-DWI, DCE-MRI, and combined models (ALN_metastasis + TIC type + D + Kep) were 0.765, 0.732, 0.771, 0.804, and 0.958 in the training cohort, respectively. The combined model significantly outperformed individual models (combined model vs. conventional MRI model, Z = 4.890, P < 0.001; combined model vs. pathological model, Z = 4.429, P < 0.001; combined model vs. IVIM model, Z = 3.724, P < 0.001; combined model vs. DCE-MRI model, Z = 3.691, P < 0.001).
CONCLUSION: The nomogram combining clinicopathological and multimodal MRI parameters can accurately predict HIF-1α expression non-invasively and assist personalized breast cancer therapy.
引用
- Zhao, Wang, Zhong, et al. Predictive Value of Nomogram-based Multiparametric MRI Combined with Pathological Biomarkers for HIF-1α Expression in Breast Cancer. Acad Radiol. 2026. PMID: 42547383. doi:10.1016/j.acra.2026.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。